Phase I study of irinotecan and doxifluridine for metastatic colorectal cancer focusing on the UGT1A1*28 polymorphism (Q43211622)
Jump to navigation
Jump to search
scientific article published on 7 November 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study of irinotecan and doxifluridine for metastatic colorectal cancer focusing on the UGT1A1*28 polymorphism |
scientific article published on 7 November 2009 |
Statements
1 reference
Phase I study of irinotecan and doxifluridine for metastatic colorectal cancer focusing on the UGT1A1*28 polymorphism (English)
1 reference
Masaaki Oka
1 reference
Shoichi Hazama
1 reference
Atsushi Nagashima
1 reference
Hiroshi Kondo
1 reference
Shin Yoshida
1 reference
Ryoichi Shimizu
1 reference
Atsuhiro Araki
1 reference
Shigefumi Yoshino
1 reference
Naoko Okayama
1 reference
Yuji Hinoda
1 reference
7 November 2009
1 reference
1 reference
101
1 reference
3
1 reference
722-727
1 reference
Identifiers
1 reference
1 reference